The bill introduces new labeling requirements for products containing or derived from aborted human fetal tissue, amending the Health and Safety Code by adding three sections: 431.085 for food products, 431.118 for medical products, and 431.143 for cosmetic products. Each section defines what constitutes a "fetal tissue product" and mandates that such products cannot be sold, dispensed, or administered in Texas unless they are clearly labeled according to rules set by the executive commissioner of the Health and Human Services Commission. The definitions include products that contain, are manufactured using, or are derived from human fetal tissue obtained from aborted unborn children.

The executive commissioner is required to adopt the form and content of the labels by December 1, 2025, and the new labeling requirements will apply to products sold or administered on or after January 1, 2026. The bill will take effect immediately if it receives a two-thirds majority vote in both houses; otherwise, it will take effect on September 1, 2025.

Statutes affected:
Introduced: ()